aMoon Alpha – Life Sciences Private Equity Firm
Yaron Daniely, PhD, head of aMoon Alpha, an internal section of aMoon, a healthtech and life sciences venture fund based in Israel, discusses his work a...
5265 articles
Yaron Daniely, PhD, head of aMoon Alpha, an internal section of aMoon, a healthtech and life sciences venture fund based in Israel, discusses his work a...
Chris House, Senior Vice President of Product Management and Development at NantHealth®, a healthcare company, discusses NaviNet®, a payer-provider co...
Andrew Blumenfeld, MD, director of the Headache Center of Southern California discusses the often misunderstood condition of migraine, how the disease i...
Laurie Keefer, PhD, a psychologist with Mount Sinai Hospital’s IBD Center in New York City who specializes in the psychosocial care of patients with c...
Bruce Boise, who worked in the pharmaceutical industry for over 20 years tells his story and discusses his new book "Cold Comfort: One man's struggle to...
Andrew Krivoshik, SVP, and Oncology Therapeutic Area Head at Astellas Pharma US discusses the overall survival findings from the Phase 3 PROSPER trial i...
Ayman Al-Hendy, MD, discusses the recent FDA approval of AbbVie’s ORIAHNN™ (elagolix, estradiol, and norethindrone acetate capsules; elagolix capsul...
Lane Conger Maples, VP of Client Experience at Bridge Connector, a company offering interoperability and integration solutions discusses the current sta...
Karim Richard Masri, a Rheumatologist at the Bon Secours Rheumatology center in Richmond, VA discusses new data released by Horizon Therapeutics at the ...
Michael Korn, Chief Medical Officer at Caris Life Sciences®, discusses the data presentation from the American Society of Clinical Oncology, (ASCO20) V...